Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Prospective Cohort of Tumors With Pole/D1 Mutation

NCT05103969 is registered in ClinicalTrials.gov with Federation Francophone de Cancerologie Digestive as lead sponsor.

NCT NCT05103969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05103969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Prospective Cohort of Tumors With Pole/D1 Mutation
Lead sponsor
Federation Francophone de Cancerologie Digestive
Phase
Observational
Overall status
Unknown status
Start date
October 5, 2021
Completion date
October 6, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pold1 gene mutation, pole exonuclease domain mutation, tumors